Trident Texofab Ltd (540726) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

BSE: 540726 | NSE: | Textile | Small Cap

Trident Texofab Share Price

61.15 -3.21 -4.99%
as on 06-Mar'26 16:59

DeciZen - make an informed investing decision on Trident Texofab

Based on:

M-Cap below 100cr DeciZen not available

Trident Texofab stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
29.95
Market Cap:
96.5 Cr.
52-wk low:
64.4
52-wk high:
379

Is Trident Texofab Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Trident Texofab: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Trident Texofab Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 9.9%15.9%16.1%13.1%14.3%9.8%9%13.1%10.3%11.4%-
Value Creation
Index
-0.30.10.2-0.10.0-0.3-0.4-0.1-0.3-0.2-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 667685.586.99149.984.396.499.5122123
Sales YoY Gr.-15.1%12.5%1.7%4.7%-45.1%68.9%14.3%3.2%22.7%-
Adj EPS 2.640.61.210.30.92.30.90.72.2
YoY Gr.-57%-84.1%90.6%-21.3%-69.8%220.7%146.2%-62.9%-22.4%-
BVPS (₹) 43.547.68.61111.811.912.815.116.131.838.3
Adj Net
Profit
0.20.30.61.20.90.30.92.30.90.93
Cash Flow from Ops. 0.70.1-2.5-2.8-2.921.45.92.7-13.7-
Debt/CF from Ops. 4.341.1-2.1-5.4-7.815.925.65.913.6-1.9-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 7.1%6.1%13.1%22.7%
Adj EPS -14%-7.2%-10.8%-22.4%
BVPS-3.4%22%35.3%97%
Share Price - 18.2% -3.9% -64%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
5.98.810.212.28.22.57.516.45.52.86.1
Op. Profit
Mgn %
1.51.51.72.85.35.85.76.66.34.66.2
Net Profit
Mgn %
0.30.40.71.410.61.12.40.90.72.6
Debt to
Equity
0.91.40.61.41.92.62.82.32.30.6-
Working Cap
Days
173136126152147304185176194196106
Cash Conv.
Cycle
223182961136989810510951

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Trident Texofab Ltd.

Standalone Consolidated
TTM EPS (₹) 2.2 -
TTM Sales (₹ Cr.) 123 -
BVPS (₹.) 38.3 -
Reserves (₹ Cr.) 43 -
P/BV 1.68 -
PE 29.95 -
From the Market
52 Week Low / High (₹) 64.36 / 379.00
All Time Low / High (₹) 13.33 / 379.00
Market Cap (₹ Cr.) 96.5
Equity (₹ Cr.) 15
Face Value (₹) 10
Industry PE 31.5

Management X-Ray of Trident Texofab:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Trident Texofab - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Trident Texofab

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales65.9875.9585.4686.9090.9649.9184.2996.3699.48122.06
Operating Expenses 64.9974.8084.0184.5086.1447.0379.5090.0593.22116.46
Manufacturing Costs00.320.420.702.410.911.5632.773.57
Material Costs62.8272.3881.9779.5178.7842.0672.2680.3983.83105.82
Employee Cost 0.900.660.671.592.111.712.062.402.282.32
Other Costs 1.281.440.952.702.832.353.634.264.344.75
Operating Profit 0.991.151.452.404.832.884.796.316.275.60
Operating Profit Margin (%) 1.5%1.5%1.7%2.8%5.3%5.8%5.7%6.5%6.3%4.6%
Other Income 0.050.240.480.320.421.850.741.900.393.30
Interest 0.600.680.770.862.712.852.833.714.154.68
Depreciation 0.140.130.130.301.011.021.471.641.651.65
Exceptional Items -0.21-0.0200.14-00.050.04-0.130.310
Profit Before Tax 0.090.561.041.691.530.901.272.731.172.58
Tax 0.030.230.290.420.630.550.290.510.090.07
Profit After Tax 0.060.330.751.270.900.350.982.221.082.51
PAT Margin (%) 0.1%0.4%0.9%1.5%1.0%0.7%1.2%2.3%1.1%2.1%
Adjusted EPS (₹)0.10.50.81.30.90.41.02.21.11.9
Dividend Payout Ratio (%)0%0%53%31%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 3.463.798.261111.6211.9812.9615.1816.2643.13
Share Capital 0.330.3344.204.2010.0710.0710.0710.0713.56
Reserves 3.133.464.276.807.431.912.895.116.1929.57
Minority Interest0000000000
Debt2.985.184.1712.8520.3729.1533.4031.7233.9823.68
Long Term Debt0.515.184.179.2510.5519.1920.2718.5817.747.43
Short Term Debt2.47003.609.819.9613.1313.1416.2416.25
Trade Payables30.8014.8430.3119.3916.0316.2211.3917.6216.6914.86
Others Liabilities 0.740.672.203.817.6610.4313.2412.7914.9718.91
Total Liabilities 37.9924.4844.9447.0455.6867.7770.9977.3181.90100.58

Fixed Assets

Gross Block1.721.732.173.2714.1816.7525.4328.5628.4628.33
Accumulated Depreciation0.390.480.610.911.702.543.725.236.738.24
Net Fixed Assets 1.331.251.562.3612.4814.2121.7123.3321.7420.08
CWIP 0006.390.308.893.62000
Investments 0.330.822.651.421.122.482.063.643.741.89
Inventories9.382.315.073.9310.118.017.2710.6413.5515.96
Trade Receivables26.0315.4032.1329.4026.4330.2830.8533.8736.6740.71
Cash Equivalents 0.161.860.230.390.080.030.040.060.163.16
Others Assets 0.762.853.293.165.153.865.435.766.0418.77
Total Assets 37.9924.4844.9447.0455.6867.7770.9977.3181.90100.58

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 0.700.13-2.45-2.75-2.851.961.395.852.71-13.72
PBT 0.090.561.041.691.530.901.272.731.172.58
Adjustment 0.080.120.131.243.682.924.644.335.793.82
Changes in Working Capital 0.61-0.38-3.19-4.94-7.56-1.63-4.52-1.07-4.13-19.81
Tax Paid -0.08-0.17-0.41-0.74-0.50-0.230-0.13-0.12-0.30
Cash Flow From Investing Activity -0.10-0.54-2.27-6.61-2.41-10.19-4.380.37-0.574.50
Capex 0.24-0.05-0.44-7.60-1.63-9.92-3.80-0.22-0.030
Net Investments -0.32-0.49-1.830.99-0.83-0.09-0.57-0.10-0.474.33
Others -0.020-0-00.05-0.19-0.010.69-0.070.17
Cash Flow From Financing Activity -0.632.113.099.594.958.192.99-6.20-2.0512.23
Net Proceeds from Shares 004.482.030000052.95
Net Proceeds from Borrowing -0.634.58-1.025.081.949.191.49-3.16-1.13-10.32
Interest Paid 000-0.86-2.41-2.73-2.22-3.39-3.78-4.31
Dividend Paid 000-0.08-0.4100000
Others 0-2.47-0.383.425.841.723.720.362.86-26.10
Net Cash Flow -0.021.69-1.620.22-0.31-0.0500.020.093

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)1.79.0712.4413.568.253.047.9115.86.888.46
ROCE (%)9.8715.916.113.1214.289.88.9513.0710.3211.43
Asset Turnover Ratio1.992.432.5521.870.821.221.311.261.35
PAT to CFO Conversion(x)11.670.39-3.27-2.17-3.175.61.422.642.51-5.47
Working Capital Days
Receivable Days12410098122106206132122128115
Inventory Days44281518276633344444
Payable Days1491151011148214070667554

Trident Texofab Ltd Stock News

Trident Texofab Ltd FAQs

The current trading price of Trident Texofab on 06-Mar-2026 16:59 is ₹61.15.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 05-Mar-2026 the market cap of Trident Texofab stood at ₹96.51.
The latest P/E ratio of Trident Texofab as of 05-Mar-2026 is 29.95.
The latest P/B ratio of Trident Texofab as of 05-Mar-2026 is 1.68.
The 52-week high of Trident Texofab is ₹379.0 and the 52-week low is ₹64.36.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Trident Texofab is ₹122.7 ( Cr.) .

About Trident Texofab Ltd

No data to display
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×